{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:21:35Z","timestamp":1786980095986,"version":"build-2736575974"},"reference-count":90,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,7,9]],"date-time":"2024-07-09T00:00:00Z","timestamp":1720483200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,7,9]],"date-time":"2024-07-09T00:00:00Z","timestamp":1720483200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["R01 AG055865"],"award-info":[{"award-number":["R01 AG055865"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["R01 AG056478"],"award-info":[{"award-number":["R01 AG056478"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000957","name":"Alzheimer's Association","doi-asserted-by":"publisher","award":["AARFD-21-851509"],"award-info":[{"award-number":["AARFD-21-851509"]}],"id":[{"id":"10.13039\/100000957","id-type":"DOI","asserted-by":"publisher"}]},{"name":"The Hertz innovation fund"},{"name":"The Gordon private foundation"},{"name":"The Wilstein Private foundation"},{"name":"The Saban private foundation"},{"name":"The Ray Charles Foundation"},{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","award":["R01 EY013431"],"award-info":[{"award-number":["R01 EY013431"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P30 AG 066530"],"award-info":[{"award-number":["P30 AG 066530"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013015","name":"Cedars-Sinai Medical Center","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100013015","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Neuropathol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    This study investigates various pathological tau isoforms in the retina of individuals with early and advanced Alzheimer\u2019s disease (AD), exploring their connection with disease status. Retinal cross-sections from predefined superior-temporal and inferior-temporal subregions and corresponding brains from neuropathologically confirmed AD patients with a clinical diagnosis of either mild cognitive impairment (MCI) or dementia (\n                    <jats:italic>n<\/jats:italic>\n                    \u2009=\u200945) were compared with retinas from age- and sex-matched individuals with normal cognition (\n                    <jats:italic>n<\/jats:italic>\n                    \u2009=\u200930) and non-AD dementia (\n                    <jats:italic>n<\/jats:italic>\n                    \u2009=\u20094). Retinal tau isoforms, including tau tangles, paired helical filament of tau (PHF-tau), oligomeric-tau (Oligo-tau), hyperphosphorylated-tau (p-tau), and citrullinated-tau (Cit-tau), were stereologically analyzed by immunohistochemistry and Nanostring GeoMx digital spatial profiling, and correlated with clinical and neuropathological outcomes. Our data indicated significant increases in various AD-related pretangle tau isoforms, especially p-tau (AT8, 2.9-fold, pS396-tau, 2.6-fold), Cit-tau at arginine residue 209 (CitR\n                    <jats:sub>209<\/jats:sub>\n                    -tau; 4.1-fold), and Oligo-tau (T22\n                    <jats:sup>+<\/jats:sup>\n                    , 9.2-fold), as well as pretangle and mature tau tangle forms like MC-1-positive (1.8-fold) and PHF-tau (2.3-fold), in AD compared to control retinas. MCI retinas also exhibited substantial increases in Oligo-tau (5.2-fold), CitR\n                    <jats:sub>209<\/jats:sub>\n                    -tau (3.5-fold), and pS396-tau (2.2-fold). Nanostring GeoMx analysis confirmed elevated retinal p-tau at epitopes: Ser214 (2.3-fold), Ser396 (2.6-fold), Ser404 (2.4-fold), and Thr231 (1.8-fold), particularly in MCI patients. Strong associations were found between retinal tau isoforms versus brain pathology and cognitive status: a) retinal Oligo-tau vs. Braak stage, neurofibrillary tangles (NFTs), and CDR cognitive scores (\n                    <jats:italic>\u03c1<\/jats:italic>\n                    \u2009=\u20090.63\u20130.71), b) retinal PHF-tau vs. neuropil threads (NTs) and ABC scores (\n                    <jats:italic>\u03c1<\/jats:italic>\n                    \u2009=\u20090.69\u20130.71), and c) retinal pS396-tau vs. NTs, NFTs, and ABC scores (\n                    <jats:italic>\u03c1<\/jats:italic>\n                    \u2009=\u20090.67\u20130.74). Notably, retinal Oligo-tau strongly correlated with retinal A\u03b2\n                    <jats:sub>42<\/jats:sub>\n                    and arterial A\u03b2\n                    <jats:sub>40<\/jats:sub>\n                    forms (\n                    <jats:italic>r<\/jats:italic>\n                    \u2009=\u20090.76\u20130.86). Overall, this study identifies and quantifies diverse retinal tau isoforms in MCI and AD patients, underscoring their link to brain pathology and cognition. These findings advocate for further exploration of retinal tauopathy biomarkers to facilitate AD detection and monitoring via noninvasive retinal imaging.\n                  <\/jats:p>","DOI":"10.1007\/s00401-024-02760-8","type":"journal-article","created":{"date-parts":[[2024,7,9]],"date-time":"2024-07-09T05:02:50Z","timestamp":1720501370000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["Identification of retinal oligomeric, citrullinated, and other tau isoforms in early and advanced AD and relations to disease status"],"prefix":"10.1007","volume":"148","author":[{"given":"Haoshen","family":"Shi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nazanin","family":"Mirzaei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yosef","family":"Koronyo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miyah R.","family":"Davis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward","family":"Robinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gila M.","family":"Braun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ousman","family":"Jallow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Altan","family":"Rentsendorj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V. Krishnan","family":"Ramanujan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justyna","family":"Fert-Bober","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrei A.","family":"Kramerov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander V.","family":"Ljubimov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lon S.","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Warren G.","family":"Tourtellotte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debra","family":"Hawes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie A.","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keith L.","family":"Black","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rakez","family":"Kayed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maj-Linda B.","family":"Selenica","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel C.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dieu-Trang","family":"Fuchs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2864-8442","authenticated-orcid":false,"given":"Maya","family":"Koronyo-Hamaoui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,7,9]]},"reference":[{"key":"2760_CR1","doi-asserted-by":"publisher","unstructured":"(2024) 2024 Alzheimer's disease facts and figures. Alzheimers Dement 20:3708\u20133821. https:\/\/doi.org\/10.1002\/alz.13809","DOI":"10.1002\/alz.13809"},{"key":"2760_CR2","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/j.jaut.2012.03.004","volume":"38","author":"NK Acharya","year":"2012","unstructured":"Acharya NK, Nagele EP, Han M, Coretti NJ, DeMarshall C, Kosciuk MC et al (2012) Neuronal PAD4 expression and protein citrullination: possible role in production of autoantibodies associated with neurodegenerative disease. J Autoimmun 38:369\u2013380. https:\/\/doi.org\/10.1016\/j.jaut.2012.03.004","journal-title":"J Autoimmun"},{"key":"2760_CR3","doi-asserted-by":"publisher","DOI":"10.1002\/alz.13529","author":"J Alber","year":"2023","unstructured":"Alber J, Bouwman F, den Haan J, Rissman RA, De Groef L, Koronyo-Hamaoui M et al (2023) Retina pathology as a target for biomarkers for Alzheimer\u2019s disease: current status, ophthalmopathological background, challenges, and future directions. Alzheimers Dement. https:\/\/doi.org\/10.1002\/alz.13529","journal-title":"Alzheimers Dement"},{"key":"2760_CR4","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1097\/WNR.0b013e3283497334","volume":"22","author":"PN Alexandrov","year":"2011","unstructured":"Alexandrov PN, Pogue A, Bhattacharjee S, Lukiw WJ (2011) Retinal amyloid peptides and complement factor H in transgenic models of Alzheimer\u2019s disease. NeuroReport 22:623\u2013627. https:\/\/doi.org\/10.1097\/WNR.0b013e3283497334","journal-title":"NeuroReport"},{"key":"2760_CR5","doi-asserted-by":"publisher","first-page":"7592851","DOI":"10.1155\/2019\/7592851","volume":"2019","author":"M Alghamdi","year":"2019","unstructured":"Alghamdi M, Alasmari D, Assiri A, Mattar E, Aljaddawi AA, Alattas SG et al (2019) An overview of the intrinsic role of citrullination in autoimmune disorders. J Immunol Res 2019:7592851. https:\/\/doi.org\/10.1155\/2019\/7592851","journal-title":"J Immunol Res"},{"key":"2760_CR6","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0232785","volume":"15","author":"S Asanad","year":"2020","unstructured":"Asanad S, Fantini M, Sultan W, Nassisi M, Felix CM, Wu J et al (2020) Retinal nerve fiber layer thickness predicts CSF amyloid\/tau before cognitive decline. PLoS ONE 15:e0232785. https:\/\/doi.org\/10.1371\/journal.pone.0232785","journal-title":"PLoS ONE"},{"key":"2760_CR7","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1167\/iovs.18-25966","volume":"60","author":"S Asanad","year":"2019","unstructured":"Asanad S, Ross-Cisneros FN, Nassisi M, Barron E, Karanjia R, Sadun AA (2019) The retina in alzheimer\u2019s disease: histomorphometric analysis of an ophthalmologic biomarker. Invest Ophthalmol Vis Sci 60:1491\u20131500. https:\/\/doi.org\/10.1167\/iovs.18-25966","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2760_CR8","doi-asserted-by":"publisher","DOI":"10.1002\/dad2.12421","volume":"15","author":"G Ashraf","year":"2023","unstructured":"Ashraf G, McGuinness M, Khan MA, Obtinalla C, Hadoux X, van Wijngaarden P (2023) Retinal imaging biomarkers of Alzheimer\u2019s disease: a systematic review and meta-analysis of studies using brain amyloid beta status for case definition. Alzheimers Dement (Amst) 15:e12421. https:\/\/doi.org\/10.1002\/dad2.12421","journal-title":"Alzheimers Dement (Amst)"},{"key":"2760_CR9","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1007\/s004010100423","volume":"103","author":"JC Augustinack","year":"2002","unstructured":"Augustinack JC, Schneider A, Mandelkow EM, Hyman BT (2002) Specific tau phosphorylation sites correlate with severity of neuronal cytopathology in Alzheimer\u2019s disease. Acta Neuropathol 103:26\u201335. https:\/\/doi.org\/10.1007\/s004010100423","journal-title":"Acta Neuropathol"},{"key":"2760_CR10","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1001\/archneur.55.3.326","volume":"55","author":"L Berg","year":"1998","unstructured":"Berg L, McKeel DW Jr, Miller JP, Storandt M, Rubin EH, Morris JC et al (1998) Clinicopathologic studies in cognitively healthy aging and Alzheimer\u2019s disease: relation of histologic markers to dementia severity, age, sex, and apolipoprotein E genotype. Arch Neurol 55:326\u2013335. https:\/\/doi.org\/10.1001\/archneur.55.3.326","journal-title":"Arch Neurol"},{"key":"2760_CR11","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1097\/WAD.0000000000000279","volume":"32","author":"L Besser","year":"2018","unstructured":"Besser L, Kukull W, Knopman DS, Chui H, Galasko D, Weintraub S et al (2018) Version 3 of the National Alzheimer\u2019s coordinating center\u2019s uniform data set. Alzheimer Dis Assoc Disord 32:351\u2013358. https:\/\/doi.org\/10.1097\/WAD.0000000000000279","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"2760_CR12","doi-asserted-by":"publisher","first-page":"4158","DOI":"10.1172\/JCI69003","volume":"123","author":"LJ Blair","year":"2013","unstructured":"Blair LJ, Nordhues BA, Hill SE, Scaglione KM, O\u2019Leary JC 3rd, Fontaine SN et al (2013) Accelerated neurodegeneration through chaperone-mediated oligomerization of tau. J Clin Invest 123:4158\u20134169. https:\/\/doi.org\/10.1172\/JCI69003","journal-title":"J Clin Invest"},{"key":"2760_CR13","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/0197-4580(96)00009-7","volume":"17","author":"JC Blanks","year":"1996","unstructured":"Blanks JC, Schmidt SY, Torigoe Y, Porrello KV, Hinton DR, Blanks RH (1996) Retinal pathology in Alzheimer\u2019s disease. II. Regional neuron loss and glial changes in GCL. Neurobiol Aging 17:385\u2013395. https:\/\/doi.org\/10.1016\/0197-4580(96)00009-7","journal-title":"Neurobiol Aging"},{"key":"2760_CR14","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1001\/jamaneurol.2013.5847","volume":"71","author":"GS Bloom","year":"2014","unstructured":"Bloom GS (2014) Amyloid-beta and tau: the trigger and bullet in Alzheimer disease pathogenesis. JAMA Neurol 71:505\u2013508. https:\/\/doi.org\/10.1001\/jamaneurol.2013.5847","journal-title":"JAMA Neurol"},{"key":"2760_CR15","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1007\/s00401-006-0127-z","volume":"112","author":"H Braak","year":"2006","unstructured":"Braak H, Alafuzoff I, Arzberger T, Kretzschmar H, Del Tredici K (2006) Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry. Acta Neuropathol 112:389\u2013404. https:\/\/doi.org\/10.1007\/s00401-006-0127-z","journal-title":"Acta Neuropathol"},{"key":"2760_CR16","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aaf2362","volume":"8","author":"MR Brier","year":"2016","unstructured":"Brier MR, Gordon B, Friedrichsen K, McCarthy J, Stern A, Christensen J et al (2016) Tau and Abeta imaging, CSF measures, and cognition in Alzheimer\u2019s disease. Sci Transl Med 8:338ra366. https:\/\/doi.org\/10.1126\/scitranslmed.aaf2362","journal-title":"Sci Transl Med"},{"key":"2760_CR17","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1167\/tvst.10.7.5","volume":"10","author":"KJ Cao","year":"2021","unstructured":"Cao KJ, Kim JH, Kroeger H, Gaffney PM, Lin JH, Sigurdso CJ et al (2021) ARCAM-1 facilitates fluorescence detection of amyloid-containing deposits in the retina. Transl Vis Sci Technol 10:5. https:\/\/doi.org\/10.1167\/tvst.10.7.5","journal-title":"Transl Vis Sci Technol"},{"key":"2760_CR18","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1007\/s00018-022-04126-3","volume":"79","author":"O Ciesielski","year":"2022","unstructured":"Ciesielski O, Biesiekierska M, Panthu B, Soszynski M, Pirola L, Balcerczyk A (2022) Citrullination in the pathology of inflammatory and autoimmune disorders: recent advances and future perspectives. Cell Mol Life Sci 79:94. https:\/\/doi.org\/10.1007\/s00018-022-04126-3","journal-title":"Cell Mol Life Sci"},{"key":"2760_CR19","doi-asserted-by":"publisher","first-page":"265","DOI":"10.3389\/fnagi.2020.00265","volume":"12","author":"P d'Errico","year":"2020","unstructured":"d\u2019Errico P, Meyer-Luehmann M (2020) Mechanisms of pathogenic tau and abeta protein spreading in Alzheimer\u2019s disease. Front Aging Neurosci 12:265. https:\/\/doi.org\/10.3389\/fnagi.2020.00265","journal-title":"Front Aging Neurosci"},{"key":"2760_CR20","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1186\/s40478-018-0650-x","volume":"6","author":"J den Haan","year":"2018","unstructured":"den Haan J, Morrema THJ, Verbraak FD, de Boer JF, Scheltens P, Rozemuller AJ et al (2018) Amyloid-beta and phosphorylated tau in post-mortem Alzheimer\u2019s disease retinas. Acta Neuropathol Commun 6:147. https:\/\/doi.org\/10.1186\/s40478-018-0650-x","journal-title":"Acta Neuropathol Commun"},{"key":"2760_CR21","doi-asserted-by":"publisher","DOI":"10.1093\/pnasnexus\/pgac164","volume":"1","author":"X Du","year":"2022","unstructured":"Du X, Koronyo Y, Mirzaei N, Yang C, Fuchs DT, Black KL et al (2022) Label-free hyperspectral imaging and deep-learning prediction of retinal amyloid beta-protein and phosphorylated tau. PNAS Nexus 1:pgac164. https:\/\/doi.org\/10.1093\/pnasnexus\/pgac164","journal-title":"PNAS Nexus"},{"key":"2760_CR22","doi-asserted-by":"publisher","DOI":"10.1002\/dad2.12109","volume":"12","author":"OM Dumitrascu","year":"2020","unstructured":"Dumitrascu OM, Lyden PD, Torbati T, Sheyn J, Sherzai A, Sherzai D et al (2020) Sectoral segmentation of retinal amyloid imaging in subjects with cognitive decline. Alzheimers Dement (Amst) 12:e12109. https:\/\/doi.org\/10.1002\/dad2.12109","journal-title":"Alzheimers Dement (Amst)"},{"key":"2760_CR23","doi-asserted-by":"publisher","DOI":"10.3390\/cells10112926","author":"OM Dumitrascu","year":"2021","unstructured":"Dumitrascu OM, Rosenberry R, Sherman DS, Khansari MM, Sheyn J, Torbati T et al (2021) Retinal venular tortuosity jointly with retinal amyloid burden correlates with verbal memory loss: a pilot study. Cells. https:\/\/doi.org\/10.3390\/cells10112926","journal-title":"Cells"},{"key":"2760_CR24","doi-asserted-by":"publisher","DOI":"10.1177\/1759091414562107","author":"L Erskine","year":"2014","unstructured":"Erskine L, Herrera E (2014) Connecting the retina to the brain. ASN Neuro. https:\/\/doi.org\/10.1177\/1759091414562107","journal-title":"ASN Neuro"},{"key":"2760_CR25","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","volume":"12","author":"MF Folstein","year":"1975","unstructured":"Folstein MF, Folstein SE, McHugh PR (1975) \u201cMini-mental state\u201d. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12:189\u2013198. https:\/\/doi.org\/10.1016\/0022-3956(75)90026-6","journal-title":"J Psychiatr Res"},{"key":"2760_CR26","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1002\/alz.13490","volume":"20","author":"S Gaikwad","year":"2024","unstructured":"Gaikwad S, Senapati S, Haque MA, Kayed R (2024) Senescence, brain inflammation, and oligomeric tau drive cognitive decline in Alzheimer\u2019s disease: evidence from clinical and preclinical studies. Alzheimers Dement 20:709\u2013727. https:\/\/doi.org\/10.1002\/alz.13490","journal-title":"Alzheimers Dement"},{"key":"2760_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.preteyeres.2024.101273","volume":"101","author":"BP Gaire","year":"2024","unstructured":"Gaire BP, Koronyo Y, Fuchs DT, Shi H, Rentsendorj A, Danziger R et al (2024) Alzheimer\u2019s disease pathophysiology in the retina. Prog Retin Eye Res 101:101273. https:\/\/doi.org\/10.1016\/j.preteyeres.2024.101273","journal-title":"Prog Retin Eye Res"},{"key":"2760_CR28","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1007\/s00702-004-0221-0","volume":"112","author":"CX Gong","year":"2005","unstructured":"Gong CX, Liu F, Grundke-Iqbal I, Iqbal K (2005) Post-translational modifications of tau protein in Alzheimer\u2019s disease. J Neural Transm (Vienna) 112:813\u2013838. https:\/\/doi.org\/10.1007\/s00702-004-0221-0","journal-title":"J Neural Transm (Vienna)"},{"key":"2760_CR29","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1212\/wnl.54.1.105","volume":"54","author":"MS Green","year":"2000","unstructured":"Green MS, Kaye JA, Ball MJ (2000) The Oregon brain aging study: neuropathology accompanying healthy aging in the oldest old. Neurology 54:105\u2013113. https:\/\/doi.org\/10.1212\/wnl.54.1.105","journal-title":"Neurology"},{"key":"2760_CR30","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1016\/S0021-9258(18)48531-6","volume":"267","author":"SG Greenberg","year":"1992","unstructured":"Greenberg SG, Davies P, Schein JD, Binder LI (1992) Hydrofluoric acid-treated tau PHF proteins display the same biochemical properties as normal tau. J Biol Chem 267:564\u2013569","journal-title":"J Biol Chem"},{"key":"2760_CR31","doi-asserted-by":"publisher","first-page":"925","DOI":"10.3389\/fnins.2019.00925","volume":"13","author":"A Grimaldi","year":"2019","unstructured":"Grimaldi A, Pediconi N, Oieni F, Pizzarelli R, Rosito M, Giubettini M et al (2019) Neuroinflammatory processes, A1 astrocyte activation and protein aggregation in the retina of alzheimer\u2019s disease patients, possible biomarkers for early diagnosis. Front Neurosci 13:925. https:\/\/doi.org\/10.3389\/fnins.2019.00925","journal-title":"Front Neurosci"},{"key":"2760_CR32","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1093\/brain\/awac329","volume":"146","author":"C Groot","year":"2023","unstructured":"Groot C, Smith R, Stomrud E, Binette AP, Leuzy A, Wuestefeld A et al (2023) Phospho-tau with subthreshold tau-PET predicts increased tau accumulation rates in amyloid-positive individuals. Brain 146:1580\u20131591. https:\/\/doi.org\/10.1093\/brain\/awac329","journal-title":"Brain"},{"key":"2760_CR33","doi-asserted-by":"publisher","first-page":"4227","DOI":"10.1038\/s41467-019-12242-1","volume":"10","author":"X Hadoux","year":"2019","unstructured":"Hadoux X, Hui F, Lim JKH, Masters CL, Pebay A, Chevalier S et al (2019) Non-invasive in vivo hyperspectral imaging of the retina for potential biomarker use in Alzheimer\u2019s disease. Nat Commun 10:4227. https:\/\/doi.org\/10.1038\/s41467-019-12242-1","journal-title":"Nat Commun"},{"key":"2760_CR34","doi-asserted-by":"publisher","DOI":"10.1007\/s00401-022-02525-1","author":"FJH de Ruyter","year":"2022","unstructured":"de Ruyter FJH, Morrema THJ, den Haan J, Netherlands Brain B, Twisk JWR, de Boer JF et al (2022) Phosphorylated tau in the retina correlates with tau pathology in the brain in Alzheimer\u2019s disease and primary tauopathies. Acta Neuropathol. https:\/\/doi.org\/10.1007\/s00401-022-02525-1","journal-title":"Acta Neuropathol"},{"key":"2760_CR35","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1056\/NEJM198608213150804","volume":"315","author":"DR Hinton","year":"1986","unstructured":"Hinton DR, Sadun AA, Blanks JC, Miller CA (1986) Optic-nerve degeneration in Alzheimer\u2019s disease. N Engl J Med 315:485\u2013487. https:\/\/doi.org\/10.1056\/NEJM198608213150804","journal-title":"N Engl J Med"},{"key":"2760_CR36","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1111\/bpa.12070","volume":"24","author":"CY Ho","year":"2014","unstructured":"Ho CY, Troncoso JC, Knox D, Stark W, Eberhart CG (2014) Beta-amyloid, phospho-tau and alpha-synuclein deposits similar to those in the brain are not identified in the eyes of Alzheimer\u2019s and Parkinson\u2019s disease patients. Brain Pathol 24:25\u201332. https:\/\/doi.org\/10.1111\/bpa.12070","journal-title":"Brain Pathol"},{"key":"2760_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jalz.2011.10.007","volume":"8","author":"BT Hyman","year":"2012","unstructured":"Hyman BT, Phelps CH, Beach TG, Bigio EH, Cairns NJ, Carrillo MC et al (2012) National Institute on Aging-Alzheimer\u2019s Association guidelines for the neuropathologic assessment of Alzheimer\u2019s disease. Alzheimers Dement 8:1\u201313. https:\/\/doi.org\/10.1016\/j.jalz.2011.10.007","journal-title":"Alzheimers Dement"},{"key":"2760_CR38","doi-asserted-by":"publisher","first-page":"5646","DOI":"10.1073\/pnas.86.14.5646","volume":"86","author":"K Iqbal","year":"1989","unstructured":"Iqbal K, Grundke-Iqbal I, Smith AJ, George L, Tung YC, Zaidi T (1989) Identification and localization of a tau peptide to paired helical filaments of Alzheimer disease. Proc Natl Acad Sci USA 86:5646\u20135650. https:\/\/doi.org\/10.1073\/pnas.86.14.5646","journal-title":"Proc Natl Acad Sci USA"},{"key":"2760_CR39","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","volume":"14","author":"CR Jack Jr","year":"2018","unstructured":"Jack CR Jr, Bennett DA, Blennow K, Carrillo MC, Dunn B, Haeberlein SB et al (2018) NIA-AA Research Framework: toward a biological definition of Alzheimer\u2019s disease. Alzheimers Dement 14:535\u2013562. https:\/\/doi.org\/10.1016\/j.jalz.2018.02.018","journal-title":"Alzheimers Dement"},{"key":"2760_CR40","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1002\/(sici)1097-4547(19970415)48:2<128::aid-jnr5>3.0.co;2-e","volume":"48","author":"GA Jicha","year":"1997","unstructured":"Jicha GA, Bowser R, Kazam IG, Davies P (1997) Alz-50 and MC-1, a new monoclonal antibody raised to paired helical filaments, recognize conformational epitopes on recombinant tau. J Neurosci Res 48:128\u2013132. https:\/\/doi.org\/10.1002\/(sici)1097-4547(19970415)48:2%3c128::aid-jnr5%3e3.0.co;2-e","journal-title":"J Neurosci Res"},{"key":"2760_CR41","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a006213","volume":"2","author":"KA Johnson","year":"2012","unstructured":"Johnson KA, Fox NC, Sperling RA, Klunk WE (2012) Brain imaging in Alzheimer disease. Cold Spring Harb Perspect Med 2:a006213. https:\/\/doi.org\/10.1101\/cshperspect.a006213","journal-title":"Cold Spring Harb Perspect Med"},{"key":"2760_CR42","doi-asserted-by":"publisher","first-page":"223","DOI":"10.2478\/s13380-012-0032-y","volume":"3","author":"KJ Kopeikina","year":"2012","unstructured":"Kopeikina KJ, Hyman BT, Spires-Jones TL (2012) Soluble forms of tau are toxic in Alzheimer\u2019s disease. Transl Neurosci 3:223\u2013233. https:\/\/doi.org\/10.2478\/s13380-012-0032-y","journal-title":"Transl Neurosci"},{"key":"2760_CR43","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.93621","author":"Y Koronyo","year":"2017","unstructured":"Koronyo Y, Biggs D, Barron E, Boyer DS, Pearlman JA, Au WJ et al (2017) Retinal amyloid pathology and proof-of-concept imaging trial in Alzheimer\u2019s disease. JCI Insight. https:\/\/doi.org\/10.1172\/jci.insight.93621","journal-title":"JCI Insight"},{"key":"2760_CR44","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1007\/s00401-023-02548-2","volume":"145","author":"Y Koronyo","year":"2023","unstructured":"Koronyo Y, Rentsendorj A, Mirzaei N, Regis GC, Sheyn J, Shi H et al (2023) Retinal pathological features and proteome signatures of Alzheimer\u2019s disease. Acta Neuropathol 145:409\u2013438. https:\/\/doi.org\/10.1007\/s00401-023-02548-2","journal-title":"Acta Neuropathol"},{"issue":"Suppl 1","key":"2760_CR45","doi-asserted-by":"publisher","first-page":"S204","DOI":"10.1016\/j.neuroimage.2010.06.020","volume":"54","author":"M Koronyo-Hamaoui","year":"2011","unstructured":"Koronyo-Hamaoui M, Koronyo Y, Ljubimov AV, Miller CA, Ko MK, Black KL et al (2011) Identification of amyloid plaques in retinas from Alzheimer\u2019s patients and noninvasive in vivo optical imaging of retinal plaques in a mouse model. Neuroimage 54(Suppl 1):S204-217. https:\/\/doi.org\/10.1016\/j.neuroimage.2010.06.020","journal-title":"Neuroimage"},{"key":"2760_CR46","doi-asserted-by":"publisher","first-page":"3706","DOI":"10.1038\/s41467-023-39328-1","volume":"14","author":"N Kyalu Ngoie Zola","year":"2023","unstructured":"Kyalu Ngoie Zola N, Balty C, Pyr Dit Ruys S, Vanparys AAT, Huyghe NDG, Herinckx G et al (2023) Specific post-translational modifications of soluble tau protein distinguishes Alzheimer\u2019s disease and primary tauopathies. Nat Commun 14:3706. https:\/\/doi.org\/10.1038\/s41467-023-39328-1","journal-title":"Nat Commun"},{"key":"2760_CR47","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1002\/ana.24548","volume":"79","author":"C La Morgia","year":"2016","unstructured":"La Morgia C, Ross-Cisneros FN, Koronyo Y, Hannibal J, Gallassi R, Cantalupo G et al (2016) Melanopsin retinal ganglion cell loss in Alzheimer disease. Ann Neurol 79:90\u2013109. https:\/\/doi.org\/10.1002\/ana.24548","journal-title":"Ann Neurol"},{"key":"2760_CR48","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1038\/srep00700","volume":"2","author":"CA Lasagna-Reeves","year":"2012","unstructured":"Lasagna-Reeves CA, Castillo-Carranza DL, Sengupta U, Guerrero-Munoz MJ, Kiritoshi T, Neugebauer V et al (2012) Alzheimer brain-derived tau oligomers propagate pathology from endogenous tau. Sci Rep 2:700. https:\/\/doi.org\/10.1038\/srep00700","journal-title":"Sci Rep"},{"key":"2760_CR49","doi-asserted-by":"publisher","first-page":"1946","DOI":"10.1096\/fj.11-199851","volume":"26","author":"CA Lasagna-Reeves","year":"2012","unstructured":"Lasagna-Reeves CA, Castillo-Carranza DL, Sengupta U, Sarmiento J, Troncoso J, Jackson GR et al (2012) Identification of oligomers at early stages of tau aggregation in Alzheimer\u2019s disease. FASEB J 26:1946\u20131959. https:\/\/doi.org\/10.1096\/fj.11-199851","journal-title":"FASEB J"},{"key":"2760_CR50","doi-asserted-by":"publisher","first-page":"758","DOI":"10.3389\/fnins.2020.00758","volume":"14","author":"S Lee","year":"2020","unstructured":"Lee S, Jiang K, McIlmoyle B, To E, Xu QA, Hirsch-Reinshagen V et al (2020) Amyloid beta immunoreactivity in the retinal ganglion cell layer of the Alzheimer\u2019s eye. Front Neurosci 14:758. https:\/\/doi.org\/10.3389\/fnins.2020.00758","journal-title":"Front Neurosci"},{"key":"2760_CR51","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1186\/s13195-020-00715-1","volume":"12","author":"S Lemmens","year":"2020","unstructured":"Lemmens S, Van Craenendonck T, Van Eijgen J, De Groef L, Bruffaerts R, de Jesus DA et al (2020) Combination of snapshot hyperspectral retinal imaging and optical coherence tomography to identify Alzheimer\u2019s disease patients. Alzheimers Res Ther 12:144. https:\/\/doi.org\/10.1186\/s13195-020-00715-1","journal-title":"Alzheimers Res Ther"},{"key":"2760_CR52","doi-asserted-by":"publisher","first-page":"963689721103370","DOI":"10.1177\/09636897211033705","volume":"30","author":"HH Liang","year":"2021","unstructured":"Liang HH, Ma C, Rocha-Rangel PV, Ocallaghan M, Quadri Z, Blair L et al (2021) Understanding tau citrullination during tauopathies and related dementias. Cell Transplant 30:9636897211033704. https:\/\/doi.org\/10.1177\/09636897211033705","journal-title":"Cell Transplant"},{"key":"2760_CR53","doi-asserted-by":"publisher","first-page":"1738","DOI":"10.1093\/brain\/awv081","volume":"138","author":"N Maphis","year":"2015","unstructured":"Maphis N, Xu G, Kokiko-Cochran ON, Jiang S, Cardona A, Ransohoff RM et al (2015) Reactive microglia drive tau pathology and contribute to the spreading of pathological tau in the brain. Brain 138:1738\u20131755. https:\/\/doi.org\/10.1093\/brain\/awv081","journal-title":"Brain"},{"key":"2760_CR54","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1001\/archneur.63.1.38","volume":"63","author":"WR Markesbery","year":"2006","unstructured":"Markesbery WR, Schmitt FA, Kryscio RJ, Davis DG, Smith CD, Wekstein DR (2006) Neuropathologic substrate of mild cognitive impairment. Arch Neurol 63:38\u201346. https:\/\/doi.org\/10.1001\/archneur.63.1.38","journal-title":"Arch Neurol"},{"key":"2760_CR55","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1212\/wnl.41.4.479","volume":"41","author":"SS Mirra","year":"1991","unstructured":"Mirra SS, Heyman A, McKeel D, Sumi SM, Crain BJ, Brownlee LM et al (1991) The Consortium to Establish a Registry for Alzheimer\u2019s Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer\u2019s disease. Neurology 41:479\u2013486. https:\/\/doi.org\/10.1212\/wnl.41.4.479","journal-title":"Neurology"},{"key":"2760_CR56","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2020.00921","author":"N Mirzaei","year":"2020","unstructured":"Mirzaei N, Shi H, Oviatt M, Doustar J, Rentsendorj A, Fuchs D-T et al (2020) Alzheimer\u2019s retinopathy: seeing disease in the eyes. Front Neurosci. https:\/\/doi.org\/10.3389\/fnins.2020.00921","journal-title":"Front Neurosci"},{"key":"2760_CR57","doi-asserted-by":"publisher","first-page":"1554","DOI":"10.1002\/alz.12321","volume":"17","author":"CM Moloney","year":"2021","unstructured":"Moloney CM, Lowe VJ, Murray ME (2021) Visualization of neurofibrillary tangle maturity in Alzheimer\u2019s disease: a clinicopathologic perspective for biomarker research. Alzheimers Dement 17:1554\u20131574. https:\/\/doi.org\/10.1002\/alz.12321","journal-title":"Alzheimers Dement"},{"key":"2760_CR58","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00401-011-0910-3","volume":"123","author":"TJ Montine","year":"2012","unstructured":"Montine TJ, Phelps CH, Beach TG, Bigio EH, Cairns NJ, Dickson DW et al (2012) National Institute on Aging-Alzheimer\u2019s Association guidelines for the neuropathologic assessment of Alzheimer\u2019s disease: a practical approach. Acta Neuropathol 123:1\u201311. https:\/\/doi.org\/10.1007\/s00401-011-0910-3","journal-title":"Acta Neuropathol"},{"key":"2760_CR59","doi-asserted-by":"publisher","first-page":"4492","DOI":"10.1021\/acschemneuro.9b00331","volume":"10","author":"SS More","year":"2019","unstructured":"More SS, Beach JM, McClelland C, Mokhtarzadeh A, Vince R (2019) In vivo assessment of retinal biomarkers by hyperspectral imaging: early detection of Alzheimer\u2019s disease. ACS Chem Neurosci 10:4492\u20134501. https:\/\/doi.org\/10.1021\/acschemneuro.9b00331","journal-title":"ACS Chem Neurosci"},{"key":"2760_CR60","doi-asserted-by":"publisher","first-page":"2412","DOI":"10.1212\/wnl.43.11.2412-a","volume":"43","author":"JC Morris","year":"1993","unstructured":"Morris JC (1993) The Clinical Dementia Rating (CDR): current version and scoring rules. Neurology 43:2412\u20132414. https:\/\/doi.org\/10.1212\/wnl.43.11.2412-a","journal-title":"Neurology"},{"key":"2760_CR61","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/NEN.0b013e3181919a48","volume":"68","author":"PT Nelson","year":"2009","unstructured":"Nelson PT, Braak H, Markesbery WR (2009) Neuropathology and cognitive impairment in Alzheimer disease: a complex but coherent relationship. J Neuropathol Exp Neurol 68:1\u201314. https:\/\/doi.org\/10.1097\/NEN.0b013e3181919a48","journal-title":"J Neuropathol Exp Neurol"},{"key":"2760_CR62","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1097\/nen.0b013e31815c5efb","volume":"66","author":"PT Nelson","year":"2007","unstructured":"Nelson PT, Jicha GA, Schmitt FA, Liu H, Davis DG, Mendiondo MS et al (2007) Clinicopathologic correlations in a large Alzheimer disease center autopsy cohort: neuritic plaques and neurofibrillary tangles \u201cdo count\u201d when staging disease severity. J Neuropathol Exp Neurol 66:1136\u20131146. https:\/\/doi.org\/10.1097\/nen.0b013e31815c5efb","journal-title":"J Neuropathol Exp Neurol"},{"key":"2760_CR63","doi-asserted-by":"publisher","DOI":"10.1002\/dad2.12199","volume":"13","author":"J Ngolab","year":"2021","unstructured":"Ngolab J, Donohue M, Belsha A, Salazar J, Cohen P, Jaiswal S et al (2021) Feasibility study for detection of retinal amyloid in clinical trials: the anti-amyloid treatment in asymptomatic Alzheimer\u2019s disease (A4) trial. Alzheimers Dement (Amst) 13:e12199. https:\/\/doi.org\/10.1002\/dad2.12199","journal-title":"Alzheimers Dement (Amst)"},{"key":"2760_CR64","doi-asserted-by":"publisher","DOI":"10.3390\/life11010028","author":"G Niewiadomska","year":"2021","unstructured":"Niewiadomska G, Niewiadomski W, Steczkowska M, Gasiorowska A (2021) Tau oligomers neurotoxicity. Life (Basel). https:\/\/doi.org\/10.3390\/life11010028","journal-title":"Life (Basel)"},{"key":"2760_CR65","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s13195-023-01375-7","volume":"16","author":"C Nunez-Diaz","year":"2024","unstructured":"Nunez-Diaz C, Andersson E, Schultz N, Poceviciute D, Hansson O, Netherlands Brain B et al (2024) The fluorescent ligand bTVBT2 reveals increased p-tau uptake by retinal microglia in Alzheimer\u2019s disease patients and App(NL-F\/NL-F) mice. Alzheimers Res Ther 16:4. https:\/\/doi.org\/10.1186\/s13195-023-01375-7","journal-title":"Alzheimers Res Ther"},{"key":"2760_CR66","unstructured":"Purves D (ed) (2001) The retina. Neuroscience, 2nd ed, Chapters 11 and 12. Sinauer Associates, Sunderland"},{"key":"2760_CR67","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1167\/tvst.9.2.47","volume":"9","author":"Y Qiu","year":"2020","unstructured":"Qiu Y, Jin T, Mason E, Campbell MCW (2020) Predicting thioflavin fluorescence of retinal amyloid deposits associated with Alzheimer\u2019s disease from their polarimetric properties. Transl Vis Sci Technol 9:47. https:\/\/doi.org\/10.1167\/tvst.9.2.47","journal-title":"Transl Vis Sci Technol"},{"key":"2760_CR68","doi-asserted-by":"publisher","DOI":"10.3390\/ijms232112841","author":"P Rawat","year":"2022","unstructured":"Rawat P, Sehar U, Bisht J, Selman A, Culberson J, Reddy PH (2022) Phosphorylated tau in Alzheimer\u2019s disease and other tauopathies. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms232112841","journal-title":"Int J Mol Sci"},{"key":"2760_CR69","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1097\/WAD.0b013e3181b76415","volume":"24","author":"HC Rossetti","year":"2010","unstructured":"Rossetti HC, Munro Cullum C, Hynan LS, Lacritz LH (2010) The CERAD Neuropsychologic Battery Total Score and the progression of Alzheimer disease. Alzheimer Dis Assoc Disord 24:138\u2013142. https:\/\/doi.org\/10.1097\/WAD.0b013e3181b76415","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"2760_CR70","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0053547","volume":"7","author":"C Schon","year":"2012","unstructured":"Schon C, Hoffmann NA, Ochs SM, Burgold S, Filser S, Steinbach S et al (2012) Long-term in vivo imaging of fibrillar tau in the retina of P301S transgenic mice. PLoS ONE 7:e53547. https:\/\/doi.org\/10.1371\/journal.pone.0053547","journal-title":"PLoS ONE"},{"key":"2760_CR71","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.3233\/JAD-190868","volume":"73","author":"N Schultz","year":"2020","unstructured":"Schultz N, Byman E, Netherlands Brain B, Wennstrom M (2020) Levels of retinal amyloid-beta correlate with levels of retinal IAPP and hippocampal amyloid-beta in neuropathologically evaluated individuals. J Alzheimers Dis 73:1201\u20131209. https:\/\/doi.org\/10.3233\/JAD-190868","journal-title":"J Alzheimers Dis"},{"key":"2760_CR72","doi-asserted-by":"publisher","first-page":"83","DOI":"10.3389\/fnagi.2017.00083","volume":"9","author":"SS Shafiei","year":"2017","unstructured":"Shafiei SS, Guerrero-Munoz MJ, Castillo-Carranza DL (2017) Tau oligomers: cytotoxicity, propagation, and mitochondrial damage. Front Aging Neurosci 9:83. https:\/\/doi.org\/10.3389\/fnagi.2017.00083","journal-title":"Front Aging Neurosci"},{"key":"2760_CR73","doi-asserted-by":"publisher","DOI":"10.1002\/alz.13086","author":"H Shi","year":"2023","unstructured":"Shi H, Koronyo Y, Fuchs DT, Sheyn J, Jallow O, Mandalia K et al (2023) Retinal arterial Abeta(40) deposition is linked with tight junction loss and cerebral amyloid angiopathy in MCI and AD patients. Alzheimers Dement. https:\/\/doi.org\/10.1002\/alz.13086","journal-title":"Alzheimers Dement"},{"key":"2760_CR74","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1007\/s00401-020-02134-w","volume":"139","author":"H Shi","year":"2020","unstructured":"Shi H, Koronyo Y, Rentsendorj A, Regis GC, Sheyn J, Fuchs DT et al (2020) Identification of early pericyte loss and vascular amyloidosis in Alzheimer\u2019s disease retina. Acta Neuropathol 139:813\u2013836. https:\/\/doi.org\/10.1007\/s00401-020-02134-w","journal-title":"Acta Neuropathol"},{"key":"2760_CR75","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1001\/jama.2023.13239","volume":"330","author":"JR Sims","year":"2023","unstructured":"Sims JR, Zimmer JA, Evans CD, Lu M, Ardayfio P, Sparks J et al (2023) Donanemab in early symptomatic alzheimer disease: the TRAILBLAZER-ALZ 2 randomized clinical trial. JAMA 330:512\u2013527. https:\/\/doi.org\/10.1001\/jama.2023.13239","journal-title":"JAMA"},{"key":"2760_CR76","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.jalz.2011.03.003","volume":"7","author":"RA Sperling","year":"2011","unstructured":"Sperling RA, Aisen PS, Beckett LA, Bennett DA, Craft S, Fagan AM et al (2011) Toward defining the preclinical stages of Alzheimer\u2019s disease: recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease. Alzheimers Dement 7:280\u2013292. https:\/\/doi.org\/10.1016\/j.jalz.2011.03.003","journal-title":"Alzheimers Dement"},{"key":"2760_CR77","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1001\/jamaneurol.2020.0387","volume":"77","author":"RA Sperling","year":"2020","unstructured":"Sperling RA, Donohue MC, Raman R, Sun CK, Yaari R, Holdridge K et al (2020) Association of factors with elevated amyloid burden in clinically normal older individuals. JAMA Neurol 77:735\u2013745. https:\/\/doi.org\/10.1001\/jamaneurol.2020.0387","journal-title":"JAMA Neurol"},{"key":"2760_CR78","doi-asserted-by":"publisher","DOI":"10.15252\/emmm.202012921","volume":"12","author":"M Suarez-Calvet","year":"2020","unstructured":"Suarez-Calvet M, Karikari TK, Ashton NJ, Lantero Rodriguez J, Mila-Aloma M, Gispert JD et al (2020) Novel tau biomarkers phosphorylated at T181, T217 or T231 rise in the initial stages of the preclinical Alzheimer\u2019s continuum when only subtle changes in Abeta pathology are detected. EMBO Mol Med 12:e12921. https:\/\/doi.org\/10.15252\/emmm.202012921","journal-title":"EMBO Mol Med"},{"key":"2760_CR79","doi-asserted-by":"publisher","first-page":"927","DOI":"10.3233\/JAD-210327","volume":"83","author":"K Tadokoro","year":"2021","unstructured":"Tadokoro K, Yamashita T, Kimura S, Nomura E, Ohta Y, Omote Y et al (2021) Retinal amyloid imaging for screening Alzheimer\u2019s disease. J Alzheimers Dis 83:927\u2013934. https:\/\/doi.org\/10.3233\/JAD-210327","journal-title":"J Alzheimers Dis"},{"key":"2760_CR80","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.1212\/wnl.58.12.1791","volume":"58","author":"DR Thal","year":"2002","unstructured":"Thal DR, Rub U, Orantes M, Braak H (2002) Phases of A beta-deposition in the human brain and its relevance for the development of AD. Neurology 58:1791\u20131800. https:\/\/doi.org\/10.1212\/wnl.58.12.1791","journal-title":"Neurology"},{"key":"2760_CR81","doi-asserted-by":"publisher","first-page":"1984","DOI":"10.1212\/01.wnl.0000129697.01779.0a","volume":"62","author":"P Tiraboschi","year":"2004","unstructured":"Tiraboschi P, Hansen LA, Thal LJ, Corey-Bloom J (2004) The importance of neuritic plaques and tangles to the development and evolution of AD. Neurology 62:1984\u20131989. https:\/\/doi.org\/10.1212\/01.wnl.0000129697.01779.0a","journal-title":"Neurology"},{"key":"2760_CR82","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1007\/s00401-007-0200-2","volume":"113","author":"T Uchihara","year":"2007","unstructured":"Uchihara T (2007) Silver diagnosis in neuropathology: principles, practice and revised interpretation. Acta Neuropathol 113:483\u2013499. https:\/\/doi.org\/10.1007\/s00401-007-0200-2","journal-title":"Acta Neuropathol"},{"key":"2760_CR83","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1056\/NEJMoa2212948","volume":"388","author":"CH van Dyck","year":"2023","unstructured":"van Dyck CH, Swanson CJ, Aisen P, Bateman RJ, Chen C, Gee M et al (2023) Lecanemab in early Alzheimer\u2019s disease. N Engl J Med 388:9\u201321. https:\/\/doi.org\/10.1056\/NEJMoa2212948","journal-title":"N Engl J Med"},{"key":"2760_CR84","doi-asserted-by":"publisher","first-page":"2612","DOI":"10.1038\/s41467-020-15701-2","volume":"11","author":"JW Vogel","year":"2020","unstructured":"Vogel JW, Iturria-Medina Y, Strandberg OT, Smith R, Levitis E, Evans AC et al (2020) Spread of pathological tau proteins through communicating neurons in human Alzheimer\u2019s disease. Nat Commun 11:2612. https:\/\/doi.org\/10.1038\/s41467-020-15701-2","journal-title":"Nat Commun"},{"key":"2760_CR85","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1186\/s40478-019-0754-y","volume":"7","author":"T Vogels","year":"2019","unstructured":"Vogels T, Murgoci AN, Hromadka T (2019) Intersection of pathological tau and microglia at the synapse. Acta Neuropathol Commun 7:109. https:\/\/doi.org\/10.1186\/s40478-019-0754-y","journal-title":"Acta Neuropathol Commun"},{"key":"2760_CR86","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s40478-022-01324-9","volume":"10","author":"JM Walker","year":"2022","unstructured":"Walker JM, Kazempour Dehkordi S, Fracassi A, Vanschoiack A, Pavenko A, Taglialatela G et al (2022) Differential protein expression in the hippocampi of resilient individuals identified by digital spatial profiling. Acta Neuropathol Commun 10:23. https:\/\/doi.org\/10.1186\/s40478-022-01324-9","journal-title":"Acta Neuropathol Commun"},{"key":"2760_CR87","doi-asserted-by":"publisher","DOI":"10.1002\/alz.13424","author":"G Walkiewicz","year":"2023","unstructured":"Walkiewicz G, Ronisz A, Van Ginderdeuren R, Lemmens S, Bouwman FH, Hoozemans JJM et al (2023) Primary retinal tauopathy: a tauopathy with a distinct molecular pattern. Alzheimers Dement. https:\/\/doi.org\/10.1002\/alz.13424","journal-title":"Alzheimers Dement"},{"key":"2760_CR88","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1093\/jnen\/nlx020","volume":"76","author":"EA Williams","year":"2017","unstructured":"Williams EA, McGuone D, Frosch MP, Hyman BT, Laver N, Stemmer-Rachamimov A (2017) Absence of Alzheimer disease neuropathologic changes in eyes of subjects with Alzheimer disease. J Neuropathol Exp Neurol 76:376\u2013383. https:\/\/doi.org\/10.1093\/jnen\/nlx020","journal-title":"J Neuropathol Exp Neurol"},{"key":"2760_CR89","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1186\/s40478-022-01448-y","volume":"10","author":"QA Xu","year":"2022","unstructured":"Xu QA, Boerkoel P, Hirsch-Reinshagen V, Mackenzie IR, Hsiung GR, Charm G et al (2022) Muller cell degeneration and microglial dysfunction in the Alzheimer\u2019s retina. Acta Neuropathol Commun 10:145. https:\/\/doi.org\/10.1186\/s40478-022-01448-y","journal-title":"Acta Neuropathol Commun"},{"key":"2760_CR90","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.707268","volume":"9","author":"H Zhang","year":"2021","unstructured":"Zhang H, Cao Y, Ma L, Wei Y, Li H (2021) Possible mechanisms of tau spread and toxicity in Alzheimer\u2019s disease. Front Cell Dev Biol 9:707268. https:\/\/doi.org\/10.3389\/fcell.2021.707268","journal-title":"Front Cell Dev Biol"}],"container-title":["Acta Neuropathologica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00401-024-02760-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00401-024-02760-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00401-024-02760-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,9]],"date-time":"2024-07-09T05:05:17Z","timestamp":1720501517000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00401-024-02760-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,9]]},"references-count":90,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["2760"],"URL":"https:\/\/doi.org\/10.1007\/s00401-024-02760-8","relation":{},"ISSN":["1432-0533"],"issn-type":[{"value":"1432-0533","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,9]]},"assertion":[{"value":"29 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 June 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 June 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 July 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"3"}}